• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

- 突变大鼠的特征,一种新型肺动脉高压模型。

Characterization of -Mutated Rat, a Novel Model of Pulmonary Hypertension.

机构信息

From the University Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin Bicêtre, France (M.L., V.C., A.B., M.K.N., A.H., C.R.-M., O.M., B.G., D.M., F.P., M. H., F.A.).

Assistance Publique Hôpitaux de Paris, Service de Pneumologie, Centre de Référence de l'Hypertension Pulmonaire, Hôpital Bicêtre, Le Kremlin Bicêtre, France (M.L., V.C., A.B., M.K.N., A.H., C.R.-M., O.M., B.G., D.M., F.P., M.H., F.A.).

出版信息

Circ Res. 2019 Sep 13;125(7):678-695. doi: 10.1161/CIRCRESAHA.119.314793. Epub 2019 Jul 26.

DOI:10.1161/CIRCRESAHA.119.314793
PMID:31347976
Abstract

RATIONALE

Pulmonary arterial hypertension is a severe lethal cardiopulmonary disease. Loss of function mutations in (potassium channel subfamily K member 3) gene, which encodes an outward rectifier K channel, have been identified in pulmonary arterial hypertension patients.

OBJECTIVE

We have demonstrated that KCNK3 dysfunction is common to heritable and nonheritable pulmonary arterial hypertension and to experimental pulmonary hypertension (PH). Finally, KCNK3 is not functional in mouse pulmonary vasculature.

METHODS AND RESULTS

Using CRISPR/Cas9 technology, we generated a 94 bp out of frame deletion in exon 1 of gene and characterized these rats at the electrophysiological, echocardiographic, hemodynamic, morphological, cellular, and molecular levels to decipher the cellular mechanisms associated with loss of KCNK3. Using patch-clamp technique, we validated our transgenic strategy by demonstrating the absence of KCNK3 current in freshly isolated pulmonary arterial smooth muscle cells from -mutated rats. At 4 months of age, echocardiographic parameters revealed shortening of the pulmonary artery acceleration time associated with elevation of the right ventricular systolic pressure. -mutated rats developed more severe PH than wild-type rats after monocrotaline exposure or chronic hypoxia exposure. -mutation induced a lung distal neomuscularization and perivascular extracellular matrix activation. Lungs of -mutated rats were characterized by overactivation of ERK1/2 (extracellular signal-regulated kinase1-/2), AKT (protein kinase B), SRC, and overexpression of HIF1-α (hypoxia-inducible factor-1 α), survivin, and VWF (Von Willebrand factor). Linked with plasma membrane depolarization, reduced endothelial-NOS expression and desensitization of endothelial-derived hyperpolarizing factor, -mutated rats presented predisposition to vasoconstriction of pulmonary arteries and a severe loss of sildenafil-induced pulmonary arteries relaxation. Moreover, we showed strong alteration of right ventricular cardiomyocyte excitability. Finally, -mutated rats developed age-dependent PH associated with low serum-albumin concentration.

CONCLUSIONS

We established the first -mutated rat model of PH. Our results confirm that KCNK3 loss of function is a key event in pulmonary arterial hypertension pathogenesis. This model presents new opportunities for understanding the initiating mechanisms of PH and testing biologically relevant therapeutic molecules in the context of PH.

摘要

背景

肺动脉高压是一种严重的致命心肺疾病。已经在肺动脉高压患者中鉴定出编码外向整流钾通道的(钾通道亚家族 K 成员 3)基因的功能丧失突变。

目的

我们已经证明,KCNK3 功能障碍与遗传性和非遗传性肺动脉高压以及实验性肺动脉高压(PH)都有关。最后,KCNK3 在小鼠肺血管中没有功能。

方法和结果

使用 CRISPR/Cas9 技术,我们在 基因的外显子 1 中产生了 94 个碱基对的移框缺失,并在电生理学、超声心动图、血液动力学、形态学、细胞和分子水平上对这些大鼠进行了特征描述,以破译与 KCNK3 缺失相关的细胞机制。使用膜片钳技术,我们通过证明从 -突变大鼠新鲜分离的肺动脉平滑肌细胞中不存在 KCNK3 电流来验证我们的转基因策略。在 4 个月大时,超声心动图参数显示肺动脉加速时间缩短,同时右心室收缩压升高。与野生型大鼠相比,暴露于单克隆毒素或慢性低氧后,-突变大鼠更易发生 PH。-突变诱导肺远端新生肌化和血管周围细胞外基质激活。-突变大鼠的特征是 ERK1/2(细胞外信号调节激酶 1/2)、AKT(蛋白激酶 B)、SRC 的过度激活以及 HIF1-α(缺氧诱导因子-1α)、survivin 和 VWF(血管性血友病因子)的过度表达。与质膜去极化相关,内皮型一氧化氮合酶表达减少和内皮衍生超极化因子脱敏,-突变大鼠表现出肺血管收缩的倾向和严重丧失西地那非诱导的肺血管松弛。此外,我们还显示右心室心肌细胞兴奋性发生强烈改变。最后,-突变大鼠出现与血清白蛋白浓度低相关的年龄依赖性 PH。

结论

我们建立了首个 -突变大鼠 PH 模型。我们的结果证实,KCNK3 功能丧失是肺动脉高压发病机制中的关键事件。该模型为理解 PH 的起始机制以及在 PH 背景下测试具有生物学相关性的治疗分子提供了新的机会。

相似文献

1
Characterization of -Mutated Rat, a Novel Model of Pulmonary Hypertension.- 突变大鼠的特征,一种新型肺动脉高压模型。
Circ Res. 2019 Sep 13;125(7):678-695. doi: 10.1161/CIRCRESAHA.119.314793. Epub 2019 Jul 26.
2
Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.钾离子通道亚家族 K 成员 3(KCNK3)有助于肺动脉高压的发展。
Circulation. 2016 Apr 5;133(14):1371-85. doi: 10.1161/CIRCULATIONAHA.115.020951. Epub 2016 Feb 24.
3
Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension.KCNK3 的缺失是与肺动脉高压相关的右心室肥厚/功能障碍的标志。
Cardiovasc Res. 2018 May 1;114(6):880-893. doi: 10.1093/cvr/cvy016.
4
Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overload.Kcnk3 功能障碍可加重左心室压力超负荷所致肺动脉高压的发展。
Cardiovasc Res. 2021 Nov 1;117(12):2474-2488. doi: 10.1093/cvr/cvab016.
5
The Impact of Heterozygous Mutations Associated With Pulmonary Arterial Hypertension on Channel Function and Pharmacological Recovery.杂合突变对肺动脉高压通道功能及药物恢复的影响。
J Am Heart Assoc. 2017 Sep 9;6(9):e006465. doi: 10.1161/JAHA.117.006465.
6
Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.Bmpr2 突变大鼠表现出肺动脉高压的肺和心脏特征。
Circulation. 2019 Feb 12;139(7):932-948. doi: 10.1161/CIRCULATIONAHA.118.033744.
7
Characterization and regulation of wild-type and mutant TASK-1 two pore domain potassium channels indicated in pulmonary arterial hypertension.特发性肺动脉高压中野生型和突变 TASK-1 双孔域钾通道的特征和调控。
J Physiol. 2019 Feb;597(4):1087-1101. doi: 10.1113/JP277275. Epub 2018 Nov 24.
8
Vitamin D deficiency downregulates TASK-1 channels and induces pulmonary vascular dysfunction.维生素 D 缺乏会下调 TASK-1 通道并导致肺血管功能障碍。
Am J Physiol Lung Cell Mol Physiol. 2020 Oct 1;319(4):L627-L640. doi: 10.1152/ajplung.00475.2019. Epub 2020 Jul 29.
9
In vivo miR-138-5p inhibition alleviates monocrotaline-induced pulmonary hypertension and normalizes pulmonary KCNK3 and SLC45A3 expression.体内 miR-138-5p 抑制可减轻野百合碱诱导的肺动脉高压并使肺 KCNK3 和 SLC45A3 的表达正常化。
Respir Res. 2020 Jul 16;21(1):186. doi: 10.1186/s12931-020-01444-7.
10
PAR-2 inhibition reverses experimental pulmonary hypertension.PAR-2 抑制可逆转实验性肺动脉高压。
Circ Res. 2012 Apr 27;110(9):1179-91. doi: 10.1161/CIRCRESAHA.111.257568. Epub 2012 Mar 29.

引用本文的文献

1
Tenascin-R aggravates Aβ production in the perforant pathway by regulating Nav1.6 activity in APP/PS1 mice.腱生蛋白-R通过调节APP/PS1小鼠穿通通路中的Nav1.6活性来加重Aβ生成。
Alzheimers Dement. 2025 Sep;21(9):e70633. doi: 10.1002/alz.70633.
2
Hypoxic Pulmonary Vasoconstriction: An Important Component of the Homeostatic Oxygen Sensing System.低氧性肺血管收缩:内稳态氧感应系统的重要组成部分。
Physiol Res. 2024 Nov 29;73(S2):S493-S510. doi: 10.33549/physiolres.935431.
3
Vitamin D receptor and its antiproliferative effect in human pulmonary arterial hypertension.
维生素 D 受体及其在人肺动脉高压中的抗增殖作用。
Sci Rep. 2024 Nov 10;14(1):27445. doi: 10.1038/s41598-024-78380-9.
4
Transcriptome analyses reveal common immune system dysregulation in PAH patients and -deficient rats.转录组分析揭示了肺动脉高压患者和基因缺陷大鼠中常见的免疫系统失调。
Pulm Circ. 2024 Oct 23;14(4):e12434. doi: 10.1002/pul2.12434. eCollection 2024 Oct.
5
Carotid Baroreceptor Stimulation Ameliorates Pulmonary Arterial Remodeling in Rats With Hypoxia-Induced Pulmonary Hypertension.颈动脉压力感受器刺激可改善缺氧性肺动脉高压大鼠的肺血管重构。
J Am Heart Assoc. 2024 Oct;13(19):e035868. doi: 10.1161/JAHA.124.035868. Epub 2024 Sep 30.
6
Pathology and pathobiology of pulmonary hypertension: current insights and future directions.肺动脉高压的病理学和病理生物学:当前的认识和未来的方向。
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01095-2024. Print 2024 Oct.
7
Unraveling the Impact of miR-146a in Pulmonary Arterial Hypertension Pathophysiology and Right Ventricular Function.解析 miR-146a 在肺动脉高压病理生理学和右心室功能中的作用。
Int J Mol Sci. 2024 Jul 24;25(15):8054. doi: 10.3390/ijms25158054.
8
Up-regulated expression of two-pore domain K channels, KCNK1 and KCNK2, is involved in the proliferation and migration of pulmonary arterial smooth muscle cells in pulmonary arterial hypertension.双孔域钾通道KCNK1和KCNK2的表达上调参与肺动脉高压中肺动脉平滑肌细胞的增殖和迁移。
Front Cardiovasc Med. 2024 Feb 12;11:1343804. doi: 10.3389/fcvm.2024.1343804. eCollection 2024.
9
Unleashing the Potential of Nrf2: A Novel Therapeutic Target for Pulmonary Vascular Remodeling.释放Nrf2的潜力:肺血管重塑的新型治疗靶点
Antioxidants (Basel). 2023 Nov 7;12(11):1978. doi: 10.3390/antiox12111978.
10
Defining the clinical validity of genes reported to cause pulmonary arterial hypertension.定义被报道可导致肺动脉高压的基因的临床有效性。
Genet Med. 2023 Nov;25(11):100925. doi: 10.1016/j.gim.2023.100925. Epub 2023 Jul 5.